Table 2 Univariate and multivariate logistic regression analysis for potential risk factors of subsequent vertebral fracture after percutaneous vertebral augmentation.
Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
Variables | Odds ratio (95% CI) | P value | Odds ratio(95% CI) | P value |
Sex (female) | 0.814 (0.459–1.444) | 0.482 | 1.151 (0.494–2.680) | 0.745 |
Age | 0.979 (0.947–1.012) | 0.219 | 1.105 (1.050–1.163) | < 0.001 |
Body mass index | 1.036 (0.946–1.134) | 0.448 | – | – |
Hyperlipemia | 1.002 (0.620–1.619) | 0.994 | 0.378 (0.171–0.837) | 0.016 |
Anti-osteoporosis drugs | 1.884 (1.158–3.065) | 0.011 | 0.762 (0.337–1.722) | 0.514 |
Chronic steroid use | 0.440 (0.190–1.019) | 0.055 | 5.340 (1.467–19.436) | 0.011 |
Prior fracture | 0.804 (0.438–1.477) | 0.482 | – | – |
Fractured site(T11-L2) | 1.370 (0.783–2.396) | 0.270 | – | – |
Type of procedure | 0.744 (0.463–1.196) | 0.223 | – | – |
Intervetebral cement leakage | 0.502 (0.291–0.865) | 0.013 | 0.762 (0.337–1.722) | 0.514 |
VBQ score (per point) | 32.469 (14.783–71.314) | < 0.001 | 23.465 (7.585–72.589) | < 0.001 |
L1 HU | 0.911 (0.891–0.931) | < 0.001 | 0.927 (0.902–0.953) | < 0.001 |
